Genomic Valley Biotech Ltd vs Integrated Capital Services Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Genomic Valley Biotech Ltd is ₹ 28.56 as of 23 Mar 15:30 . The P/E Ratio of Genomic Valley Biotech Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Integrated Capital Services Ltd changed from 3.9 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Genomic Valley Biotech Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Integrated Capital Services Ltd changed from ₹ 7.41 crore on March 2021 to ₹ 15.23 crore on March 2025 . This represents a CAGR of 15.50% over 5 years The revenue of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Integrated Capital Services Ltd for the Dec '25 is ₹ 0.48 crore as compare to the Sep '25 revenue of ₹ 0.26 crore. This represent the growth of 84.62% The ebitda of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Integrated Capital Services Ltd for the Dec '25 is ₹ -0.44 crore as compare to the Sep '25 ebitda of ₹ 0.07 crore. This represent the decline of -728% The net profit of Genomic Valley Biotech Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Integrated Capital Services Ltd changed from ₹ -0.08 crore to ₹ -0.6 crore over 7 quarters. This represents a CAGR of 216.25% The Dividend Payout of Genomic Valley Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Integrated Capital Services Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Genomic Valley Biotech Ltd

Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.
The Company is extensively involved in commercial greenhouse / poly house cultivation of crops.
Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses,NFT & DFT etc,manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer.
Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

About Integrated Capital Services Ltd

Integrated Capital Services Limited (ICSL) was incorporated on 3rd February 1993.
The Company is rendering Corporate Advisory & Consulting, Expert Services in Turnaround & Restructuring, Business Combinations, Takeovers, Mergers & Amalgamations and Accounting Services.
The Company was earlier into Business Advisory and Consulting Services.
ICSL is a member of Indo German Chambers of Commerce (IGCC), BTG Global Advisory and The Institute of Internal Auditors. At present, the business is managed by the Board of Directors.
The Board is supported by an expert team of professionals recognized for their integrity, competence and practical experience. During the year 2015, the Company redeemed 1,05,000 7% Cumulative, Non Convertible and Redeemable Preference Shares of Rs. 100/- each, at par, upon the holder of such shares exercising options to put the same for redemption.

FAQs for the comparison of Genomic Valley Biotech Ltd and Integrated Capital Services Ltd

Which company has a larger market capitalization, Genomic Valley Biotech Ltd or Integrated Capital Services Ltd?

Market cap of Genomic Valley Biotech Ltd is 8 Cr while Market cap of Integrated Capital Services Ltd is 16 Cr

What are the key factors driving the stock performance of Genomic Valley Biotech Ltd and Integrated Capital Services Ltd?

The stock performance of Genomic Valley Biotech Ltd and Integrated Capital Services Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Genomic Valley Biotech Ltd and Integrated Capital Services Ltd?

As of March 23, 2026, the Genomic Valley Biotech Ltd stock price is INR ₹28.56. On the other hand, Integrated Capital Services Ltd stock price is INR ₹4.7.

How do dividend payouts of Genomic Valley Biotech Ltd and Integrated Capital Services Ltd compare?

To compare the dividend payouts of Genomic Valley Biotech Ltd and Integrated Capital Services Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.